Longevity Investors
Forum

Omri Amriav-Drory is a scientist and entrepreneur, currently serving as the General Partner at NFX Bio. He is the Founder and CEO of Renewal Bio, a company focused on developing innovative solutions in the field of biotechnology. Omri previously founded Genome Compiler, which was acquired by Twist Bioscience, and has played a pivotal role in scaling and investing in influential techbio companies. His unique blend of scientific expertise and entrepreneurial experience makes him a significant figure in the techbio industry.

Anastasiya Giarletta is a prominent figure in the longevity and biotech sectors, serving as an advisor and co-founder of Aikora Health and an investor at R42 Group. Based in Silicon Valley and London, she focuses on connecting venture funds, angels, and entrepreneurs within the early-stage longevity ecosystem. Anastasiya is also a Teaching Assistant at Stanford University School of Medicine, where she lectures on Longevity Venture Capital and Healthcare Venture Capital. Her extensive network and expertise make her a key influencer in advancing healthcare and human aging technologies.

Phil Newman is the Founder and CEO of Longevity.Technology, a leading media and investment platform focused on the longevity megatrend. He has held multiple C-level management positions, applying his marketing and business development expertise in sectors such as longevity, IoT, bionics, medical devices, biopharma, and 3D manufacturing. Phil's work aims to bring together innovators and investors to commercialize companies that will form the longevity economy.

Dr. Emil Kendziorra is the Founder and CEO of Tomorrow.Bio, a startup dedicated to advancing biostasis (cryonics) research and providing human cryopreservation services. He graduated summa cum laude from the University of Göttingen and has extensive experience in cancer research and entrepreneurship. Dr. Kendziorra has founded and led multiple tech and medical startups, including MedLanes and onFeedback. His vision is to build an organization that significantly contributes to the field of cryonics and promotes public awareness about its potential.

Nils Regge is a serial entrepreneur and investor with a strong passion for health and biotechnology. He is the co-founder and Managing Director of Apollo Health Ventures, a venture capital fund focused on aging and age-related diseases. Nils has founded several successful companies, including TruVenturo and HomeToGo, and has been involved in numerous financing rounds. His expertise in growing early-stage startups and his commitment to advancing biomedicine make him a key player in the longevity sector.

Karl Pfleger is a prominent angel investor and advocate for longevity research, known for his significant contributions to the biotech industry. He is an investor in Repair Biotechnologies, focusing on gene therapy for age-related diseases, and runs Aging Biotech Info, a valuable resource for the longevity community. Karl's background in machine learning and his dedication to supporting groundbreaking research make him a key figure in the fight against aging.

Ole Mensching, Ph.D., is the co-founder and General Partner of Apollo Ventures, a venture capital fund dedicated to aging and age-related diseases. He has a strong background in investment and operations, previously co-founding CareerTeam, a successful headhunting agency. Ole holds a Ph.D. from the University of California, Berkeley, and the University of Cologne, and his expertise in HR and team building has been instrumental in supporting Apollo's portfolio companies.

Sebastian Brunemeier is a biotech venture capitalist and company builder focused on longevity and regenerative medicine. He is the co-founder and General Partner of Healthspan Capital and the CEO and founder of ImmuneAGE Bio, a company dedicated to immune system rejuvenation. Sebastian has co-founded several longevity biotech companies, contributing to significant advancements in the field. His extensive experience and dedication to improving human healthspan have made him a respected figure in the biotech industry.

David Gobel is a philanthropist, entrepreneur, inventor, and futurist, best known for co-founding the Methuselah Foundation, which focuses on extending healthy human lifespans through regenerative medicine and biotechnology. He has been a driving force in promoting the concept of longevity escape velocity and has supported numerous projects and companies aimed at combating age-related diseases. David's visionary work continues to inspire advancements in the field of life extension.

Anar Isman is the co-founder and CEO of AgelessRx, a telemedicine platform dedicated to slowing down the aging process through scientifically-backed interventions. With a background in investment management, Anar transitioned to the field of longevity science driven by a desire to make a meaningful impact on human health. He believes in making cutting-edge longevity treatments accessible to everyone and is passionate about advancing the field to help people live healthier, longer lives.

Aykut Karaalioglu is an accomplished entrepreneur and investor, best known for founding MobileAction, a company specializing in app discovery and optimization. He has held various leadership roles, including CEO of SearchAds.comand Growth Lead at ScoreBeyond. Aykut is also an active angel investor and advisor to several startups, leveraging his extensive experience in product management and user acquisition to drive innovation and growth in the tech industry.

Matthew "Oki" O'Connor is the Co-CEO of Cyclarity Therapeutics, a company focused on developing treatments for cardiovascular diseases through innovative cyclodextrin technology. With a Ph.D. in Biochemistry and extensive research experience in aging and regenerative medicine, O'Connor has made significant contributions to the field. His work aims to eliminate toxic oxidized cholesterol, a major factor in atherosclerosis, and improve overall healthspan.

Mac Davis is the founder of Minicircle, a pioneering company focused on revolutionizing gene therapy. With a mission to enhance human health and sovereignty, he developed a reversible human genetic enhancement protocol that uses non-inflammatory, non-heritable plasmids to safely introduce genes into the body without altering the genome. Mac’s innovative approach challenges traditional medical practices, offering a fast, accessible, and ethical alternative to lifelong treatments. His work aims to empower individuals and communities, ensuring that gene therapy is available to all, free from the constraints of the current healthcare system.

Parmita Mishra is a computational biologist and entrepreneur, known for founding Precigenetics, a company focused on developing advanced non-invasive diagnostic tools that integrate biophotonics with machine learning. She is dedicated to pushing the boundaries of healthcare technology, particularly in the field of non-invasive cancer diagnostics. Parmita's work aims to enhance the identification of molecular signatures unique to cancerous cells, leveraging machine learning algorithms to improve detection and classification.

Kevin Caldwell is the co-founder, President, and CEO of Ossium Health, a pioneering bioengineering company focused on creating the world's first bone marrow bank for transplants. With a background in physics and economics from MIT and a JD from Harvard Law School, Kevin has also worked as an Engagement Manager at McKinsey and a Senior Investment Associate at Bridgewater Associates. His diverse experience and dedication to improving human health through innovative solutions make him a significant figure in the biotech industry.

Petr Sramek is a visionary entrepreneur and investor dedicated to advancing human health and longevity. As the co-founder, chairman, and managing partner of Longevitytech.fund, he focuses on supporting innovative startups that aim to extend healthy lifespans. Petr is also the founder and CEO of HealthyLongevity.clinic and HealthyLongevity.cafe, where he works on personalized health strategies and longevity solutions. With a background in engineering and extensive experience in the tech industry, Petr is committed to building the infrastructure needed to accelerate the adoption of health-span improving technologies.

Nish Bhat is an entrepreneur and investor with extensive experience in biotechnology and venture capital. He is the Founder and General Partner of Carbon Silicon Ventures, a firm dedicated to supporting startups that integrate engineering principles with biological sciences to drive innovation in healthcare. Before establishing Carbon Silicon Ventures, Mr. Bhat co-founded Color Health, Inc. in 2013, a company specializing in genetic testing services for various hereditary cancers. He also co-founded SciFounders, a venture capital firm launched in 2021, and serves on the board of Reference Medicine, a company focused on making specimens more affordable and accessible for oncology diagnostic developers. His journey reflects a commitment to advancing the intersection of biology and engineering, aiming to transform healthcare through innovative solutions.

‍

Dr. Dave Messina is an entrepreneur and scientist with over 25 years of experience in computational biology and human genetics. He serves as General Partner at Pioneer Fund and leads the Future of Health Fund. Prior to joining Pioneer Fund, Dr. Messina co-founded Cofactor Genomics, a company specializing in RNA and machine-learning-based diagnostics, where he led the development and clinical application of innovative diagnostic tools. Through his leadership at Pioneer Fund, he aims to advance the development of innovative health and biotechnology solutions, leveraging his extensive experience to support groundbreaking startups in the industry.

Boyang Wang is an entrepreneur and investor with a strong background in computer science and a passion for the gaming and longevity industries. He is the founder of Immortal Dragons, a purpose-driven longevity fund dedicated to advancing research and innovation in life extension technologies. In addition to his entrepreneurial ventures, Boyang actively contributes to the longevity community. He serves as a senior venture fellow at Healthspan Capital, one of the most active longevity-focused venture capital funds. His engagement extends to speaking at conferences and participating in podcasts, where he shares insights on the convergence of technology, gaming, and life extension. Through his diverse endeavors, Boyang Wang continues to influence both the gaming industry and the field of longevity, driving forward initiatives that blend technological advancement with human health and well-being.